Table 1 Patient demographic and baseline clinical characteristics
| Characteristic | VEM1-IPI (n = 46) |
|---|---|
| Age, years | |
| Mean (SD) | 55.0 (14.20) |
| Gender, n (%) | |
| Male | 37 (80.4) |
| ECOG performance status, n (%) | |
| 0 | 35 (76.1) |
| 1 | 11 (23.9) |
| Disease stage at study entry, n (%) | |
| III | 8 (17.4) |
| IV | 38 (82.6) |
| M-stage at study entry, n (%) | |
| M0 | 6 (13.0) |
| M1a | 8 (17.4) |
| M1b | 8 (17.4) |
| M1c | 24 (52.2) |
| Number of disease sites, n (%) | |
| 1 | 2 (4.3) |
| 2 | 8 (17.4) |
| 3 | 7 (15.2) |
| 4 | 4 (8.7) |
| ≥ 5 | 25 (54.3) |